# FDA Inspection 1275919 - Daiichi Sankyo Europe GmbH - July 18, 2025

Source: https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-europe-gmbh/02cc4ef0-7e2f-4314-a0e8-7193ad8f6f8f
Source feed: FDA_Inspections

> FDA Inspection 1275919 for Daiichi Sankyo Europe GmbH on July 18, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1275919
- Company Name: Daiichi Sankyo Europe GmbH
- Inspection Date: 2025-07-18
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: Office of Inspections and Investigations

## Related Documents

- [FDA Inspection 1073797 - 2018-10-19](https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-europe-gmbh/cd18cb9e-a7b8-4e13-b0b3-97e8c2e677a4)
- [FDA Inspection 882156 - 2014-05-15](https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-europe-gmbh/be78a751-86d5-4f80-8db5-7d35b11742e6)
- [FDA Inspection 802508 - 2012-09-20](https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-europe-gmbh/e6cefea5-b87a-4664-869f-ead78f0482a8)
- [FDA Inspection 649526 - 2010-01-29](https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-europe-gmbh/26f9628c-64d1-415c-9547-71f547d8540b)

Company: https://www.keypedia.com/companies/daiichi-sankyo-europe-gmbh/772636a4-cbb8-47ae-8aa1-fdc45ab325f6

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8